Navigation Links
febit Appoints Michelle Lyles, Ph.D., Vice President, Marketing and Sales

MEDFORD, Mass. and HEIDELBERG, Germany, March 10 /PRNewswire/ -- febit holding gmbh today announced the appointment of Michelle Lyles, Ph.D., to the newly created position of vice president, marketing and sales. She will be based in febit inc.'s U.S. headquarters, which is located near Boston in Medford, Mass.

Lyles will manage the US marketing and sales initiatives for febit's genomics technology products and services. These initiatives will include the company's launch of the Geniom(R) RT Analyzer, a fully automated instrument for the hybridization, washing, staining and scanning of microarrays, in the second quarter of this year.

"This is an exciting phase for febit, with the upcoming launch of the Geniom RT Analyzer," said Cord. F. Staehler, president and CEO of febit. "The addition of Michelle to the growing febit team is an important step -- in expanding our presence in the USA, the world's most important market for innovative genomics research products and services."

Lyles has extensive sales and marketing experience in the life sciences industry. Prior to joining febit, she was director of sales with Sigma-Aldrich Corp.'s research biotechnology business unit, where she successfully grew key businesses, built the sales team and created sales processes. Before this, Lyles was vice president of sales and marketing with Genospectra Inc. Earlier in her career, she was a technology manager for high-throughput screening (HTS) systems with PerkinElmer Inc., and product manager for the BioChip Array and sales development manager for HTS assay platforms with Packard Biosciences Co.

"I am thrilled to help bring febit's technology offering to full fruition by putting it in the hands of the life sciences research community," said Lyles. "febit's pioneering technology and team of highly experienced scientists position the company as a leader in genomics."

Lyles earned her Ph.D. in biochemistry at Baylor College of Medicine and completed post-doctoral training at Emory University. She holds a B.S. in biology and a B.S. in chemistry from the University of New Orleans.

About febit

febit enables scientists to read, write and understand the code of life: DNA. With its unique Geniom technology products and services, febit is the only company that puts the control for simplified genomics research directly into users' hands. Geniom exploits cutting-edge microarray technology for the analysis and synthesis of genes and genomes, providing superior time- and cost-efficiency combined with an unsurpassed spectrum of applications. Many world-renowned institutions and companies use Geniom today to drive their basic and applied research. For more information, visit


febit holding gmbh Russo Partners, LLC

Eva Sterzel David Schull or Wendy Lau

Public Relations Manager +1-212-845-4271

+49 (6221) 6510-300

SOURCE febit
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Elusys Therapeutics Appoints Robert Gundel as Vice President of Research
2. Spectral appoints Anthony Bihl to Board of Directors
3. Tianyin Pharmaceutical Appoints Three New Independent Board Members
4. Hiemstra Appoints Robert C. Glines as Director of Business Development
5. Tengion Appoints Jeff Randall to Board of Directors
6. Ambrx Appoints Douglas Axelrod Senior Vice President for Clinical Research and Development
7. BioStorage Technologies Appoints Dr. Wolfgang Hoffer as Managing Director of European Operations
8. Stem Cell Company t2cure Appoints Dr Rueck Head of Clinical Operations
9. Human Genome Sciences Appoints Maxine Gowen, Ph.D., to Its Board Of Directors
10. ImmunoVaccine Technologies appoints the Honourable Michael Kirby as Chair
11. China Technology Appoints Deloitte Touche Tohmatsu CPA as Independent Auditor
Post Your Comments:
(Date:11/24/2015)... , Nov. 24, 2015 /CNW/ - iCo Therapeutics ... today reported financial results for the quarter ended ... expressed in Canadian dollars and presented under International ... United States ," said Andrew Rae ... advancements regarding iCo-008 are not only value enriching ...
(Date:11/24/2015)... ... November 24, 2015 , ... International Society for ... of the premier annual events for pharmaceutical manufacturing: 2015 Annual Meeting. The conference ... ISPE hosted the largest number of attendees in more than a decade. ...
(Date:11/24/2015)... , Nov. 24, 2015  Clintrax Global, Inc., a worldwide provider ... , today announced that the company has set a new ... 391% quarter on quarter growth posted for Q3 of 2014 to ... and Mexico , with the establishment of an ... 2015. --> United Kingdom and ...
(Date:11/24/2015)... PA (PRWEB) , ... November 24, 2015 , ... This ... entrepreneurs at competitive events in five states to develop and pitch their BIG ideas ... projects from each state are competing for votes to win the title of SAP's ...
Breaking Biology Technology:
(Date:11/19/2015)... 2015  Although some 350 companies are actively involved ... few companies, according to Kalorama Information. These include Roche Diagnostics, ... market share of the 6.1 billion-dollar molecular testing market, ... for Molecular Diagnostic s .    ... controlled by one company and only a handful of ...
(Date:11/17/2015)... Paris from 17 th until ... from 17 th until 19 th November ... has invented the first combined scanner in the world which scans ... Until now two different scanners were required: one for passports ... on the same surface. This innovation is an ideal solution ...
(Date:11/17/2015)... , Nov. 17, 2015 Pressure BioSciences, Inc. ... the development and sale of broadly enabling, pressure cycling ... sciences industry, today announced it has received gross proceeds ... million Private Placement (the "Offering"), increasing the total amount ... or more additional closings are expected in the near ...
Breaking Biology News(10 mins):